Endoscopy Room, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China (mainland).
Department of Epidemiology and Health Statistics, Basic Medical College of Zhejiang University of Traditional Chinese Medicine, Hangzhou, Zhejiang, China (mainland).
Med Sci Monit. 2019 Aug 18;25:6313-6320. doi: 10.12659/MSM.914815.
BACKGROUND The aim of the study was to identify a multigene prognostic factor in patients with gastric cancer (GC). MATERIAL AND METHODS Random survival forest (RSF) was performed to screen survival-related genes and develop a multigene combination based on the cumulative hazard function of each GC patient in TCGA-STAD and GSE15459. Kaplan-Meier curve and univariate and multivariable Cox proportional hazards regression model were applied to evaluate the prognostic performance of the 5-gene combination. C-index was used to compare the prognostic performance of the 5-gene combination and another 9-gene signature in GC. Gene set enrichment analysis (GSEA) was conducted. RESULTS We obtained 19 survival-related genes through univariate Cox proportional hazards analysis in the training set, 5 of which were identified and were used to develop a 5-gene combination through RSF. Patients in the 5-gene combination low-risk group had better overall survival (OS) than those in the 5-gene combination high-risk group, and the 5-gene combination was demonstrated to be an independent prognostic factor in patients with GC. The 5-gene combination outperformed the 9-gene signature in predicting the OS of GC patients, and it might affect the prognosis of GC patients through E2F signaling, MYC signaling, and G2M checkpoint. CONCLUSIONS We introduce a 5-gene combination that can predict the survival of GC patients and might be an independent prognostic factor in GC.
本研究旨在确定胃癌(GC)患者的多基因预后因素。
随机生存森林(RSF)用于筛选与生存相关的基因,并基于 TCGA-STAD 和 GSE15459 中每个 GC 患者的累积危险函数,开发多基因组合。Kaplan-Meier 曲线、单变量和多变量 Cox 比例风险回归模型用于评估 5 基因组合的预后性能。C 指数用于比较 5 基因组合和 GC 中另一个 9 基因特征的预后性能。进行了基因集富集分析(GSEA)。
我们通过训练集中的单变量 Cox 比例风险分析获得了 19 个与生存相关的基因,其中 5 个被鉴定并通过 RSF 用于开发 5 基因组合。5 基因组合低风险组的患者总生存(OS)优于 5 基因组合高风险组,并且 5 基因组合是 GC 患者的独立预后因素。5 基因组合在预测 GC 患者的 OS 方面优于 9 基因特征,并且它可能通过 E2F 信号、MYC 信号和 G2M 检查点影响 GC 患者的预后。
我们提出了一个 5 基因组合,可以预测 GC 患者的生存情况,并且可能是 GC 的一个独立预后因素。